MedTrace Logo

Peer-led Psycho-education for Schizophrenia

NCT03246932 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 342

Last updated 2026-03-19

No results posted yet for this study

Summary

Profession-led psycho-education programs for people with schizophrenia are evidenced to improve patients' knowledge about the illness, mental state and relapse rate. Nevertheless, other benefits to patients, for example, their functioning and insight into illness or to be substantive in a longer term (\>12 months) are inconsistent and uncertain, especially in Asian populations. This single-blind multi-site randomized clinical trial was to test the effects of a peer-expert-led psycho-education group intervention (in addition to usual care) for adult patients with schizophrenia spectrum disorders over a 24-month follow-up, in comparison to a profession-led psycho-education group or treatment-as-usual only.

Conditions

Interventions

BEHAVIORAL

Peer-led psycho-education group

A structured, researcher-designed peer-led psycho-education program (6 months), comprising of 12 bi-weekly, 2-hour group sessions.

BEHAVIORAL

Profession-led psycho-education group

A psychoeducation group program (12 sessions, bi-weekly).

OTHER

Routine psychiatric care

Routine psychiatric outpatient care, or Treatment-as-usual (TAU).

Sponsors & Collaborators

  • Hospital Authority, Hong Kong

    collaborator OTHER_GOV

  • Jilin University Medical Science Division

    collaborator UNKNOWN

  • Taipei Medical University

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • WT Chien, PhD · CUHK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2025-05-31
Completion
2025-09-30

Countries

  • China
  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03246932 on ClinicalTrials.gov